Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated With rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care

NCT02386839 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02386839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02386839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated With rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
March 26, 2015
Completion date
September 28, 2021
Enrollment
76 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity (rop)